Total Funding
62
Total FundingVenture - Series Unknown raised
Growth Score in past quarter
pts
Heat Score 62 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1060001
Exponential Biotherapies develops therapeutics to attenuate overreactions of the immune system.
- Dirk-Jan van Suchtelen: Chief executive officer
- Niels Bakker: Chief financial officer
About the Company
Exponential Biotherapies operates as a drug discovery and development company. It provides small molecule drugs to treat a range of severe inflammatory disorders, such as acute kidney injury, septic shock, radiation sickness, and avian influenza infections.